The hope is that the new generic will drive down rising costs of EpiPens.
THE FOOD AND DRUG Administration has approved the first generic version of the EpiPen to treat emergent and potentially life-threatening allergic reactions.
The generic version of EpiPen and EpiPen Jr., manufactured by Teva Pharmaceuticals, received the FDA’s stamp of approval this week to market its generic epinephrine auto-injector in two different strengths, according to a press release from the agency.
Its approval is a welcomed move among the devices’ users who have been facing enormous price hikes of the EpiPens. These devices are crucial to those suffering from allergies, some so severe they can send a person into anaphylaxis, which can be deadly. Although no prices have been announced, it is expected to be less expensive than current EpiPens, which cost hundreds of dollars.
“Today’s approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our …
Everyday illnesses, aches and pains can set you back at work and at home.
Our commitment is to get you back to your daily activities quickly. CONTACT US HERE